Uttar Pradesh government is set to invest approximately Rs 8,000 crore in a proposed bulk drug park situated in Lalitpur district, covering an extensive 1,472 acres across five villages in the Bundelkhand region.

Managed by the UP State Industrial Development Authority (UPSIDA), the Lalitpur bulk drug park is a strategic initiative to establish Uttar Pradesh as a prominent hub for pharmaceuticals, generic medicines, and medical devices in South Asia.

The project involves the immediate development of 300 acres of land, with the state government having already inked 236 memoranda of understanding (MoUs) worth Rs 11,000 crore with various companies and consortiums for the establishment of manufacturing plants.

Mayur Maheshwari, CEO of UPSIDA, highlighted the significance of the pharma park project in driving industrial growth and economic development in Uttar Pradesh. He emphasized that it would play a crucial role in contributing to the pharmaceutical sector, creating economic opportunities, and solidifying the state's position on the industrial landscape.

Under the new UP Pharma Policy 2023, the Lalitpur bulk drug park will focus on bulk drugs, starting/raw materials, and active pharmaceuticals. Adani Gas has been engaged to supply piped natural gas (PNG) to the park.